Literature DB >> 26600227

Hepatitis C: Issues in Children.

Christine K Lee1, Maureen M Jonas2.   

Abstract

Hepatitis C infection is a global health problem. Most infected children have not been identified. Perinatal transmission is the most common mode of acquisition. Liver disease owing to chronic hepatitis C virus (HCV) infection progresses slowly in individuals infected early in life. Serious complications rarely affect patients during childhood. Successful treatment of HCV in adults has improved and recommendations have changed. Treatment in children should be deferred until direct-acting antivirals and interferon-free regimens are available to this population. If treatment cannot be deferred, regimens including peginterferon and ribavirin can be given to children with compensated liver disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Children; Direct acting antiviral; Hepatitis C; Pegylated interferon; Perinatal transmission; Ribavirin

Mesh:

Substances:

Year:  2015        PMID: 26600227     DOI: 10.1016/j.gtc.2015.07.011

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  4 in total

1.  Hepatitis C: Review of the Epidemiology, Clinical Care, and Continued Challenges in the Direct Acting Antiviral Era.

Authors:  Alexander J Millman; Noele P Nelson; Claudia Vellozzi
Journal:  Curr Epidemiol Rep       Date:  2017-04-20

Review 2.  Hepatitis C virus infection in children and adolescents.

Authors:  James E Squires; William F Balistreri
Journal:  Hepatol Commun       Date:  2017-03-23

3.  Where are the children in national hepatitis C policies? A global review of national strategic plans and guidelines.

Authors:  Farihah Malik; Heather Bailey; Polin Chan; Intira Jeannie Collins; Antons Mozalevskis; Claire Thorne; Philippa Easterbrook
Journal:  JHEP Rep       Date:  2021-01-15

4.  Treatment and monitoring of children and adolescents with hepatitis C in Russia: Results from a multi-centre survey on policy and practice.

Authors:  Farihah Malik; Vladimir Chulanov; Nikolay Pimenov; Anastasia Fomicheva; Rebecca Lundin; Nataliia Levina; Claire Thorne; Anna Turkova; Giuseppe Indolfi
Journal:  J Virus Erad       Date:  2022-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.